News Section | Women Health
Simple ovarian cancer test to be available in 2-yrs after faulty gene discovery
The “landmark” discovery of a single faulty gene, which increases a woman’s risk of ovarian cancer six-fold, has paved the way for a simple a diagnostic test that could be available in two years.
Women with the gene have a one in 11 chance of getting the disease, and they generally have a one in 70 chance of developing it.
Each year around 6,500 new cases of ovarian cancer are reported in the UK and more than 4,000 women die from it. It has few early symptoms and is often diagnosed at a late and dangerous stage.
“There is real hope on the horizon that drugs specifically targeted to the gene will be available,” the Daily Express quoted study author Nazneen Rahman, of the Institute of Cancer Research, as saying.
Cancer Research UK’s Professor Harpal Kumar added: “We hope this will have a significant impact in providing more personalised treatments for patients based on their genetic make-up.”
Disclaimer: Bioscholar is not intended to provide medical advice, diagnosis or treatment. The articles are based on peer reviewed research, and discoveries/products mentioned in the articles may not be approved by the regulatory bodies.